Table 1.
Astaxanthin | Adonixanthin | |||
---|---|---|---|---|
Compounds | Pre-treatment | 4 h After the Final Oral Administration | Pre-treatment | 4 h after the Final Oral Administration |
trans-Astaxanthin | N.D. | 6.04 ± 1.16 | ||
cis-Astaxanthin | N.D. | 13.4 ± 3.78 | ||
trans-Adonixanthin | N.D. | 34.7 ± 3.00 | ||
cis-Adonixanthin | N.D. | 35.02 ± 5.01 |
Data are shown as mean ± SEM (n = 4). ng/mL. N.D.; not detected.